Clinical Trial Update: Safety and Efficacy of CMX-2043 in Subjects Undergoing Coronary Reperfusion Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial results report safety and efficacy of CMX-2043 in patients undergoing coronary reperfusion therapy, including those undergoing percutaneous corona…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• CMX-2043 (CMX-2043)

Snippet

Sponsor: Ischemix, LLC | Conditions: Stable Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 2 | Status: COMPLETED